Current Report Filing (8-k)
November 02 2018 - 9:34AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
October 30, 2018
Sintx
Technologies, Inc.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-33624
|
|
84-1375299
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
1885
West 2100 South
Salt
Lake City, UT 84119
(Address
of principal executive offices, including Zip Code)
Registrant’s
telephone number, including area code:
(801) 839-3500
Amedica
Corporation
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§
230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
As
previously disclosed, on October 1, 2018, Amedica Corporation (the “
Company
”) consummated the previously announced
sale of certain of the Company’s assets pursuant to that certain Asset Purchase Agreement dated September 5, 2018 (the “
Purchase
Agreement
”) by and among the Company, US Spine Inc., a Delaware corporation and wholly owned subsidiary of the Company
(“
US Spine
”) and CTL Medical Corporation, a Delaware corporation (“
CTL
”), which provided
that the Company and US Spine would, among other things, sell, transfer, and assign to CTL certain assets and liabilities related
to the Company’s and US Spine’s business, including all rights to the name “Amedica.”
On
October 30, 2018, as required by the Purchase Agreement, the Company filed a Certificate of Amendment to its Restated Certificate
of Incorporation reflecting its corporate name change to “Sintx Technologies, Inc.” effective as of October
30, 2018. The Company also amended its bylaws to reflect its corporate name change to “Sintx Technologies, Inc.”
effective as of October 30, 2018. Copies of the Certificate of Amendment and of the amendment to the bylaws are attached hereto
as Exhibit 3.1 and Exhibit 3.2, respectively, and are incorporated herein by reference.
In
connection with its name change, the new CUSIP number for the Company’s shares of common stock is 829392109.
Item
9.01 Financial Statements and Exhibits.
EXHIBIT
INDEX
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
|
Sintx
Technologies, Inc.
|
|
|
|
|
|
Date:
|
November
2, 2018
|
|
By:
|
/s/
B. Sonny Bal
|
|
|
|
|
B.
Sonny Bal
|
|
|
|
|
Chief
Executive Officer
|
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Jun 2024 to Jul 2024
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Jul 2023 to Jul 2024